Literature DB >> 16886848

Acoustic analysis of voice in patients treated by reconstructive subtotal laryngectomy. Evaluation and critical review.

V Di Nicola1, M L Fiorella, D A Spinelli, R Fiorella.   

Abstract

Aim of this investigation was to analyse the voice in a group of 20 patients submitted to supracricoid partial laryngectomy (cricohyoidopexy, sparing two arytenoids) by the Multi Dimensional Voice Programme acoustic analysis system. Results revealed the following sound characteristics: high rate of noise, lack of periodic component of the signal, high rate of segments with no sound signal, vocal segments with marked air-turbulent flow, variation amplitude and frequency coefficients doubled compared to normal values, average fundamental frequency, if present, extremely variable and unsteady. These results show that the phonatory ability of the residual larynx, due to the altered anatomo-physiology of the structure after surgery, has to be completely re-estimated. In fact, the residual larynx determines a definitely reduced periodic acoustic signal, rich in noise and which can not be modulated. Good phonatory results of this treatment are basically due to preservation of a still understandable (but not perfect!) speech which, by ensuring the subjects' speech ability, overcomes and has little influence on the really poor quality of the vocal signal in these patients. However, the patient obtains a "new voice" as far as concerns acoustic features and this is very important for communication and social life. Moreover, the possibility of objectively estimating acoustic vocal function ability allows monitoring of the trend and results of possible speech therapy and/or phonosurgical rehabilitation treatment which should start from new anatomical and physiological bases, as well as from the new physical acoustic mechanism of signal production.

Entities:  

Mesh:

Year:  2006        PMID: 16886848      PMCID: PMC2639982     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  42 in total

1.  A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS).

Authors:  P H Dejonckere; P Bradley; P Clemente; G Cornut; L Crevier-Buchman; G Friedrich; P Van De Heyning; M Remacle; V Woisard
Journal:  Eur Arch Otorhinolaryngol       Date:  2001-02       Impact factor: 2.503

Review 2.  [Objective evaluation of dysphonia. Possibilities and limitations].

Authors:  V Di Nicola; M L Fiorella; P Luperto; A Staffieri; R Fiorella
Journal:  Acta Otorhinolaryngol Ital       Date:  2001-02       Impact factor: 2.124

3.  Assessing efficacy of voice treatments: a guideline.

Authors:  P H Dejonckere
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  2000

4.  Voice after supracricoid laryngectomy: subjective, objective and self-assessment data.

Authors:  A Schindler; E Favero; S Nudo; M Spadola-Bisetti; F Ottaviani; O Schindler
Journal:  Logoped Phoniatr Vocol       Date:  2005       Impact factor: 1.487

5.  Multidimensional assessment of voice and speech after supracricoid laryngectomy with cricohyoidopexy.

Authors:  Ali Vefa Yücetürk; Kivanç Günhan
Journal:  J Laryngol Otol       Date:  2004-10       Impact factor: 1.469

6.  Perceptual evaluation of substitution voices: development and evaluation of the (I)INFVo rating scale.

Authors:  M B J Moerman; J P Martens; M J Van der Borgt; M Peleman; M Gillis; P H Dejonckere
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-25       Impact factor: 2.503

7.  Larynx preservation with supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Correlation of videostroboscopic findings and voice parameters.

Authors:  Gregory S Weinstein; Ollivier Laccourreye; Cesar Ruiz; Patricia Dooley; Ara Chalian; Natasha Mirza
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-01       Impact factor: 1.547

8.  Multidimensional Voice Program (MDVP) and amplitude variation parameters in euphonic adult subjects. Normative study.

Authors:  M Nicastri; G Chiarella; L V Gallo; M Catalano; E Cassandro
Journal:  Acta Otorhinolaryngol Ital       Date:  2004-12       Impact factor: 2.124

9.  [Assessment of quality of life in patients treated by supracricoid partial laryngectomy with cricohyoidoepiglottopexy (CHEP)].

Authors:  J A Márquez Moyano; R Sánchez Gutiérrez; J Roldán Nogueras; P Ostos Aumente; P López Villarejo
Journal:  Acta Otorrinolaringol Esp       Date:  2004-11

10.  Clinical implementation of a multidimensional basic protocol for assessing functional results of voice therapy. A preliminary study.

Authors:  P H Dejonckere
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  2000
View more
  5 in total

1.  Relationships between pathological patterns and vocal qualities estimated by acoustic parameters.

Authors:  Young-Jae Park; Young-Bae Park
Journal:  Chin J Integr Med       Date:  2015-05-03       Impact factor: 1.978

2.  Voice estimation in patients after reconstructive subtotal laryngectomy.

Authors:  Bożena Wiskirska-Woźnica; Małgorzata Leszczyńska; Hanna Czerniejewska; Joanna Jackowska; Szyfter Witold
Journal:  Head Neck Oncol       Date:  2011-10-26

3.  Acoustic voice analysis in the COVID-19 era.

Authors:  Giada Cavallaro; Vincenzo Di Nicola; Nicola Quaranta; Maria Luisa Fiorella
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-11-24       Impact factor: 2.124

4.  Supratracheal laryngectomy: current indications and contraindications.

Authors:  G Succo; M Bussi; L Presutti; S Cirillo; E Crosetti; A Bertolin; L Giordano; G Molteni; M Petracchini; A E Sprio; G N Berta; A Fornari; G Rizzotto
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-06       Impact factor: 2.124

5.  Unravelling the risk factors that underlie laryngeal surgery in elderly.

Authors:  E Crosetti; A Caracciolo; G Molteni; A E Sprio; G N Berta; L Presutti; G Succo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-06       Impact factor: 2.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.